• Flag of Canada ... pharmaceutical consulting info ... in English Flag of Brazil ... pharmaceutical consulting info ... in Portuguese Flag of Argentina ... pharmaceutical consulting info ... in Spanish
MarcM Consulting Canada letterhead with logo



THIS RSS NEWSFEED IS AVAILABLE IN ENGLISH ONLY

The international regulatory affairs consultants at MarcM Consulting Canada ("MarcM") have over twenty years of accrued knowledge and industry expertise in Latin America, the United States, Canada and elsewhere. Specializing in pharmaceutical and related industries, MarcM's team is uniquely positioned to leverage its experience with Latin American markets and its multiple language skills (English, Portuguese and Spanish) to provide exceptional service, indispensable technical guidance and overall value in pharmaceutical consulting to its clients.

In early 2008, David Emerson, Canada's then-International Trade Minister, was quoted as saying that "We have to open our doors to trade, investment, knowledge, science and technology. As countries around the world do the same, including our partners and friends in Latin America and the Caribbean, the opportunities to do business and create a better life for our people will multiply infinitely."

In contrast, challenges presented by import tariffs, tax and regulatory systems, labour markets and infrastructure sometimes confront foreign companies looking to do business elsewhere. It is in these areas, throughout the Americas and globally, that MarcM can assist with gathering market intelligence, developing local contacts, surmounting language barriers and manoeuvering mazes of regulatory restrictions. And by analyzing the strengths and weaknesses of client companies and their local and global competitors, MarcM can help businesses to meet the needs of the various markets within North and South America, and internationally.

REGULATORY AFFAIRS CONSULTANTS  MarcM Consulting Canada  ™ "Bringing the Americas Closer Together"

Furthermore, since product registration (inclusive of GMP inspections, clinical research/trials, bioequivalence studies and DMF preparations) is frequently a major constraint on export sales because of its complexity, expense and time-consuming nature, MarcM can save time and money for its clients via proper preparation of the necessary technical documents. With the help of MarcM's regulatory guidance, submissions for pharmaceuticals, drugs, medical devices, cosmetics and many other goods can be expedited.

The result for clients is a rapid improvement in export opportunities, concomitant market capitalization and cost savings.

Pharmaceutical Sales Through Retail Pharmacies in the Americas
Market update in billions US$ **

12 months to September 2010

12 months to September 2011

12 months to September 2012

North America

$242.2

up  4%

$249.3

up  3%

$258.2

    0%

USA

$223.0

up  4%

$229.4

up  3%

$238.8

    0%

Canada

$  19.2

up  5%

$  19.9

down 2%

$  19.4

    0%








Latin America
(Top 4)

$  34.2

up  *na

$  39.6

up 18%

$  41.8

up 19%

Brazil

$  16.7

up 20%

$  21.3

up 19%

$  21.7

up 17%

Mexico

$    7.6

up   2%

$    8.3

up   3%

$    8.1

up   3%

Venezuela

$    6.1

up 30%

$    5.3

up 29%

$    6.7

up 48%

Argentina

$    3.8

up 24%

$    4.7

up 30%

$    5.4

up 24%

Source: IMS HEALTH, with permission.

Sales figures here cover direct and indirect pharmaceutical channel purchases from pharmaceutical wholesalers and manufacturers. Figures include prescription and certain over-the-counter data, and represent manufacturer prices. For the USA, retail, foodstore and mail order pharmacy channels are included. In other countries sales monitored are limited to retail pharmacies only.
*na This percentage was not made available by IMS HEALTH, perhaps as the result of an oversight.
** Growth rates are calculated at a constant exchange rate (i.e., at the local currency level).

As the accompanying table suggests, although the size of the North American pharmaceutical market is large in comparison to that of the balance of the western hemisphere, the rate of growth in sales of pharmaceuticals, drugs, medicines and related products is significantly greater in Latin America. Moreover, this rapid growth in combination with the availability of wider competitive opportunities in Latin America creates commercial potential in the south of the Americas that in many respects rivals that of the hemispheric north. Brazil, for example, with an economy ranked in the top ten globally -- second overall in the western hemisphere -- and with its mature industries and surging economic expansion, annually conducts billions of dollars in trade with Canada. In 2011, Canadian exports to Brazil totalled $2.8 billion whereas imports from Brazil were even greater at $3.9 billion. In recent years, Brazil has also become Canada's 8th largest foreign investor with the latter attaining 11th position in Brazil. Thus, without having to scour more distant locales around the globe, client companies from Argentina in the south to Canada in the north can use MarcM's regulatory compliance and business development services to take full advantage of the huge scope for entrepreneurial expansion within the Americas.

In summary, given the numerous cultural differences, diverse regulatory agencies & procedures, myriad of medical and pharmaceutical practices & standards and often critical process timelines of regional markets the world over, success in frequently hard-to-access markets is grounded in the cultural relationships, experience and knowledge of a regulatory team with an accomplished local track record.

MarcM Consulting Canada, working with you as your regulatory partner, can and will provide exceptional, personalized and expert service as an integral component in building and protecting your company's brand and profits throughout the Americas and globally.

TOP

Home About MarcM Services Community Links Contact

™ "Bringing the Americas Closer Together"
© 2005-2013, MarcM Consulting Canada. All rights reserved.

Copyright and Terms of Use Policy
Privacy Policy